Cargando…

m(6)A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism

The limited effect of adjuvant therapy for advanced bladder cancer (BCa) leads to a poor prognosis. Increasing evidence has shown that RNA N6-methyladenosine (m(6)A) modification plays important functional roles in tumorigenesis. Nevertheless, the role and mechanism of m6A-modified noncoding RNAs (n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peihua, Fan, Benyi, Othmane, Belaydi, Hu, Jiao, Li, Huihuang, Cui, Yu, Ou, Zhenyu, Chen, Jinbo, Zu, Xiongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475447/ https://www.ncbi.nlm.nih.gov/pubmed/36168624 http://dx.doi.org/10.7150/thno.71456

Ejemplares similares

Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
por: Othmane, Belaydi, et al.
Publicado: (2022)

A Poliovirus Receptor (CD155)-Related Risk Signature Predicts the Prognosis of Bladder Cancer
por: Luo, Cong, et al.
Publicado: (2021)

Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette–Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis
por: Cai, Zhiyong, et al.
Publicado: (2021)

Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study
por: Yi, Zhenglin, et al.
Publicado: (2021)

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
por: Hu, Jiao, et al.
Publicado: (2021)

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer
por: Liu, Zhi, et al.
Publicado: (2021)

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer
por: Hu, Jiao, et al.
Publicado: (2021)

miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression
por: Ren, Wenbiao, et al.
Publicado: (2021)

N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
por: Guo, Tao, et al.
Publicado: (2021)

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
por: Li, Huihuang, et al.
Publicado: (2021)

A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer
por: Liu, Zhi, et al.
Publicado: (2021)

N(6)-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
por: Quan, Chao, et al.
Publicado: (2021)

PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer
por: Qiu, Dongxu, et al.
Publicado: (2021)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis
por: Cai, Zhiyong, et al.
Publicado: (2021)

S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8(+) T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2023)

Comparison of clinical feasibility and oncological outcomes between video endoscopic and open inguinal lymphadenectomy for penile cancer: A systematic review and meta-analysis
por: Hu, Jiao, et al.
Publicado: (2019)

A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study
por: Li, Huihuang, et al.
Publicado: (2022)

Clinicopathological characteristics and survival outcomes for testicular choriocarcinoma: a population-based study
por: Li, Huihuang, et al.
Publicado: (2021)

Development and validation of a predictive nomogram for the risk of recurrence in patients with cystitis glandularis
por: Hu, Jiao, et al.
Publicado: (2020)

Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma
por: Li, Yangle, et al.
Publicado: (2021)

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study
por: Hu, Jiao, et al.
Publicado: (2022)

Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis
por: Cheng, Chunliang, et al.
Publicado: (2021)

Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients: A meta-analysis based on retrospective studies
por: Chen, Jinbo, et al.
Publicado: (2019)

A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma
por: Hu, Jiao, et al.
Publicado: (2020)

A comprehensive evaluation of differentially expressed mRNAs and lncRNAs in cystitis glandularis with gene ontology, KEGG pathway, and ceRNA network analysis
por: Li, Chao, et al.
Publicado: (2020)

BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
por: Cai, Zhiyong, et al.
Publicado: (2023)

THEM6: A Novel Molecular Biomarker Predicts Tumor Microenvironment, Molecular Subtype, and Prognosis in Bladder Cancer
por: Zhao, Xu, et al.
Publicado: (2022)

ATXN3 promotes prostate cancer progression by stabilizing YAP
por: Wu, Longxiang, et al.
Publicado: (2023)

Primary mucinous adenocarcinoma of the renal pelvis misdiagnosed as calculous pyonephrosis: a case report and literature review
por: Li, Huihuang, et al.
Publicado: (2020)

Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis
por: Qiu, Dongxu, et al.
Publicado: (2020)

Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies
por: Hu, Jiao, et al.
Publicado: (2019)

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
por: Jia, Si-Qi, et al.
Publicado: (2022)

SOX5 promotes cell growth and migration through modulating DNMT1/p21 pathway in bladder cancer: SOX5/DNMT1/p21 pathway in BC
por: Wu, Longxiang, et al.
Publicado: (2022)

Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa‐miR‐132‐3p/Sox5 signalling pathway
por: Liu, Peihua, et al.
Publicado: (2019)

Smoking status and pathological response to neoadjuvant chemotherapy among patients with bladder cancer: a pooled analysis
por: He, Tongchen, et al.
Publicado: (2021)

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
por: Zhang, Chunyu, et al.
Publicado: (2023)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Silencing of MEG3 attenuated the role of lipopolysaccharides by modulating the miR-93-5p/PTEN pathway in Leydig cells
por: Zhou, Xu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d6b7s1gpm5aknf82inihhmth1r